The País reports a situation where weight loss medications are not allowed to be officially advertised in Spain according to current health regulations.
Lack of authorization for advertisements
According to an article published by El País on November 8, 2026, weight-loss pharmaceuticals are prohibited from public advertising under the existing regulatory framework. This measure aims to prevent misinformation and ensure people receive clear information about medical risks and benefits.
Distribution outside the regulated scope
Despite this legal restriction, products promoted as treatments for weight loss are widely available on urban streets and digital platforms. The presence of these unauthorized ads occurs both in physical stores and on social media and private websites.
The article highlights that the market for dietary supplements and over-the-counter medications is growing rapidly, although the lack of regulatory oversight allows widespread dissemination without prior medical evaluation.